Page 159 - MI-2-4
P. 159

Microbes & Immunity                                                  A novel anti-EphA8 monoclonal antibody



            to EphA8 and EphA10. The EphB subfamily consists   10a, a promoter of cancer invasion, leads to increased
            of five members, such as EphB1 to EphB4 and EphB6.   EphA8 expression and suppression of cancer progression
            Eight ephrin ligands have been identified, including   in colorectal cancer and glioma. 27,28  Further research is
            glycosylphosphatidylinositol-anchored ephrin A1 to   necessary to clarify the role of EphA8 in either promoting
            A5 and transmembrane ephrin B1 to B3. Following the   or suppressing cancer-related functions.
            binding to receptors, forward signaling is activated on the   Various  monoclonal  antibodies  (mAbs)  against
            receptor side, and reverse signaling is generated on the   human Eph receptors, including EphA2,  EphB2,  and
                                                                                                 29
                                                                                                        30
                                                          3
            ligand side, controlling various biological homeostasis.    EphB4,  have previously been developed by the Cell-
                                                                     31
            Eph receptors play critical roles in the nervous system   Based Immunization and Screening (CBIS) method.
            (EphA3, EphA4,  EphA5, EphB1,  EphB2,  and EphB3),    This method preserves the native structure of membrane
                                                         4,5
            cardiovascular system (EphB4),  immune system (EphA1,   proteins  during  immunization and  enables  the  efficient
                                     6
            EphA2, EphA3, EphA4, EphA7, EphA10, EphB1, EphB2,   generation of antibodies that recognize modifications
            EphB4, and EphB6),  and gastrointestinal system (EphB2   and/or three-dimensional structures of the extracellular
                            7
            and EphB3). 8                                      domains of membrane proteins. Since flow cytometry is
              EphA8 complementary DNA (cDNA) was first isolated   used for high-throughput screening in the CBIS method,
            from a rat brain cDNA library and named eek (eph- and   mAbs suitable for this application are prioritized. However,
            elk-related kinase, EEK) in 1991.  Another group cloned   anti-EphA8 mAbs suitable for flow cytometry are not yet
                                       9
            the mouse EphA8 molecule in 1997.  EphA8 is one of the   available.  Therefore,  the  establishment  of  anti-EphA8
                                         10
            members of the RTK family, and its regulatory mechanism   mAbs is essential to support basic research and preclinical
            is thought to be based on tyrosine kinase (TK) activity.   studies related to cancer therapy.
            Phosphorylation of Tyr-615 in the EphA8 juxtamembrane   In this study, an  anti-human EphA8 mAb (clone
            domain mediates a strong association with the SH2 domain   Ea Mab-9) suitable for flow cytometry was successfully
                                                                 8
            of Fyn, a member of the Src TKs.  Phosphorylation   established using the CBIS method.
                                           11
            of Tyr-838 in the EphA8 kinase domain modulates
            Fyn binding to Tyr-615, resulting in attenuation of cell   2. Materials and methods
            adhesion through cellular cytoskeletal modifications.
                                                         11
            Interestingly, TK activity-independent functions of EphA8   2.1. Cell lines and stable transfectants
            are  also  emerging.  Ephrin  A5-induced  EphA8-integrin   LN229, Chinese hamster ovary (CHO)-K1, and
            interaction is promoted by phosphatidylinositol 3-kinase   P3X63Ag8U.1 (P3U1) cells were obtained from the
            in a TK-independent manner.  Similar to representative   American Type  Culture Collection (USA). The cDNA
                                    12
            growth factor receptors such as epidermal growth factor   encoding human EphA8 (Accession No. NM_020526;
            receptor, Eph receptors play a role in cell proliferation   Catalog No.: RC220352) was purchased from OriGene
            primarily through forward signaling. 13,14  In addition to   Technologies Inc. (USA). The open reading frame of
            regulating cell-cell attachment and cell motility, EphA8   EphA8, excluding the signal sequence, was subcloned into
            is involved in organ development and axon growth. 15,16    the pCAG-Ble vector (FUJIFILM Wako Pure Chemical
            EphA8 induces caspase-dependent apoptotic cell death   Corporation, Japan) with either an interleukin 2-signal
            of ephrin A5-expressing neural epithelial cells during   sequence and PA16 tag or a MAP16 tag at the N-terminus,
            early brain development.  Loss of EphA8 disrupts   using the in-fusion HD Cloning Kit (Takara Bio Inc.,
                                  15
            axon guidance during mammalian nervous system      Japan). The resulting plasmid was transfected into the cell
            development.  Furthermore, EphA8 facilitates neurite   lines using the Neon Transfection System (Thermo Fisher
                       16
            outgrowth by sustaining mitogen-activated protein kinase   Scientific Inc., USA). Subsequently, LN229 and CHO-
            activity in neuronal cells. 17                     K1  cells stably overexpressing EphA8 with a deletion
              EphA8 expression has also been reported to be    of amino acids 1 – 27 and an N-terminal MAP16 tag
            associated with cancer. 2,18-21  EphA8 upregulation is   (hereafter described as LN229/EphA8 and CHO/EphA8,
            observed in various cancers, including oral tongue   respectively), as well as LN229 cells stably overexpressing
            squamous  cell carcinoma (OTSCC),  ovarian  cancer,    EphA8 with the same deletion and an N-terminal PA16
                                          22
                                                         23
            gastric cancer,  and breast cancer.  EphA8 and ephrin A5   tag (hereafter described as LN229/PA16-EphA8), were
                       24
                                       25
            contribute to the invasiveness of stem cells isolated from   established using a cell sorter (SH800, Sony Corp., Japan).
            MDA-MB-231, a triple-negative invasive breast cancer cell   cDNAs for various Eph receptors were obtained,
               26
            line.  In contrast, tumor suppressor functions of EphA8   including EphA1 (Catalog No.: RC213689, Accession
            have also been proposed. Reducing expression of miR-  No.:  NM_005232),  EphA4  (Catalog  No.:  RC211230,
            Volume 2 Issue 4 (2025)                        151                           doi: 10.36922/MI025060010
   154   155   156   157   158   159   160   161   162   163   164